Monthly Archives: August 2012

Admissibility of Disclaimers – New Lessons From The EPO Technical Boards of Appeal

The following is a guest post from the 8/12 newsletter of Dr. Stefan Danner of DHS Patentanwaltsgesellschaft mbH.  Last year, the EPO Enlarged Board of Appeal (EBA) handed down its decision in case G2/10 relating to the admissibility of disclaimers whose … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment

Chisum Patent Academy Announced 2013 Seminar Dates

This seminar series, taught by Donald Chisum, the leading authority on evolution  in patent law, and my former law clerk, Prof. Janice Mueller, explore contemporary developments in patent law in detail.  How about a session on how to respond to … Continue reading

Posted in Conferences and Classes | Tagged , , , , | Leave a comment

Federal Circuit Opinion On Myriad Remand

Today, the Federal Circuit issued its opinion following GVR from the Supreme Court in AMP v. USPTO and Myriad Genetics, Inc., App. No. 2010-1406 (August 16,2012). (A copy of the opinion is available at the end of this post.) Unfortunately, … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , | 1 Comment

USPTO Publishes Rule Package on AIA Administrative Trials

While this is primarily a biotechnology patent law blog, the USPTO’s high level of rule making activity deserves attention, as it will affect us all after the September 16th deadline for implementing many of the new features of the AIA … Continue reading

Posted in AIA Patent Reform | Tagged , , , , , , , | Leave a comment